| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 65.455 | 53.184 | 35.046 | 25.281 | 20.555 | 24.188 | 24.258 | 24.333 | 19.557 | 14.919 |
| Total Income - EUR | 65.547 | 53.184 | 35.531 | 25.713 | 20.567 | 24.232 | 25.259 | 26.400 | 19.557 | 14.919 |
| Total Expenses - EUR | 7.742 | 9.272 | 12.088 | 16.262 | 19.058 | 18.714 | 17.847 | 18.406 | 18.850 | 17.330 |
| Gross Profit/Loss - EUR | 57.806 | 43.912 | 23.443 | 9.450 | 1.509 | 5.518 | 7.412 | 7.995 | 707 | -2.411 |
| Net Profit/Loss - EUR | 55.839 | 42.639 | 22.210 | 9.198 | 892 | 4.849 | 6.735 | 7.344 | 142 | -2.495 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Alfa Cardiovascular Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 103.345 | 102.199 | 153.676 | 148.413 | 172.059 | 158.862 | 145.445 | 136.595 | 125.031 | 113.760 |
| Current Assets | 50.808 | 22.410 | 1.520 | 1.885 | 1.819 | 3.792 | 1.981 | 2.452 | 3.574 | 8.298 |
| Inventories | 420 | 233 | 186 | 1.627 | 1.332 | 1.344 | 1.481 | 2.118 | 3.387 | 5.111 |
| Receivables | 7.920 | 3.220 | 47 | 41 | 2 | 26 | 2 | 318 | 67 | 476 |
| Cash | 42.467 | 18.957 | 1.287 | 217 | 485 | 2.422 | 498 | 16 | 121 | 2.710 |
| Shareholders Funds | 100.611 | 83.975 | 104.764 | 112.039 | 110.762 | 113.511 | 117.728 | 125.438 | 125.200 | 122.005 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 53.542 | 40.633 | 50.432 | 38.265 | 63.238 | 47.258 | 28.770 | 13.602 | 3.523 | 165 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 2.001 | 1.046 | 150 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7739 - 7739" | |||||||||
| CAEN Financial Year |
7739
|
|||||||||
Comments - Alfa Cardiovascular Srl